Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host
its first quarter 2014 investor update conference call and webcast at
8:30 a.m. Eastern Time on Tuesday, April 29, 2014. Individuals
interested in participating in the call should dial (877) 643-7155 (U.S.
and Canada) or (914) 495-8552 (international) using conference ID number
3733415. To access the webcast, please visit the Investors section of
Ironwood’s website at www.ironwoodpharma.com
at least 15 minutes prior to the start of the call to ensure adequate
time for any software downloads that may be required.
The call will be available for replay via telephone starting April 29,
2014 at approximately 11:30 a.m. Eastern Time, running through 11:59
p.m. Eastern Time on May 6, 2014. To listen to the replay, dial (855)
859-2056 (U.S. and Canada) or (404) 537-3406 (international) using
conference ID number 3733415. The archived webcast will be available on
Ironwood’s website for 14 days beginning approximately one hour after
the call has completed.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines
that make a difference for patients, building value to earn the
continued support of our fellow shareholders, and empowering our team to
passionately pursue excellence. We discovered, developed and are
commercializing linaclotide, which is approved in the United States, the
European Union, and a number of other countries. Our pipeline priorities
include exploring further opportunities for linaclotide, as well as
leveraging our therapeutic expertise in gastrointestinal disorders and
our pharmacologic expertise in guanylate cyclases to address patient
needs across the upper and lower gastrointestinal tract. Ironwood was
founded in 1998 and is headquartered in Cambridge, Mass. Connect with us
at www.ironwoodpharma.com
or on Twitter at www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely posted
in both these locations.
Copyright Business Wire 2014